Showing 73–84 of 140 results

Pifeltro (doravirine)

£583.80£1,181.69
Pifeltro (doravirine) is prescription medicine that is used together with other antiviral medicines. to treat HIV-1 infected adults.

Piqray (alpelisib)

£6,748.65
Piqray (alpelisib) is a medication used in combination with fulvestrant for the treatment of postmenopausal women, and men, with hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative, PIK3CAmutated, advanced or metastatic breast cancer as detected by an FDA-approved test following progression on or after an endocrine-based regimen.

Portrazza (necitumumab)

£7,241.93
Portrazza (necitumumab) is a medication used for the treatment of metastatic squamous non-small cell lung cancer. This medicine has been approved in The US, Canda and Europe. We can get you the US FDA approved stock.

Radicut (edaravone)

£800.00
Radicut (edaravone) is a medication for the treatment of patients with amyotrophic lateral sclerosis (ALS) and acute ischaemic stroke. Radicut contains the same active ingredient as Radicava – edaravone – but they are marketed under different brand names. We at everyone.org source Radicut (edaravone) for patients.

Reblozyl (luspatercept)

£1,055.00£3,495.99
Reblozyl (luspatercept) is a medication used for the treatment of adults with anemia (low red blood cells) associated with beta thalassemia or myelodysplastic syndromes.

Relumina

£1,053.31
Relumina (relugolix) is a medication used for the management of the symptoms following symptoms associated with uterine fibroids: excessive menstruation, abdominal pain, low back pain, anaemia.

Repatha (evolocumab)

£550.00
Repatha (evolocumab) is a medication used with other medicines to treat people with high blood cholesterol levels (hypercholesterolemia) and cardiovascular disease.

Requip (ropinirole)

£55.68£448.39
Requip (ropinirole) is a prescription medicine for the treatment of Parkinson’s disease and moderate–to-severe primary Restless Legs Syndrome 1. Requip (ropinirole) is widely approved, including by the FDA in the USA, the EMA in the EU, and the MHRA in the UK.

Rezurock (belumosudil)

£15,157.42
Rezurock (belumosudil) is a medication used to treat chronic graft-versus-host disease (cGVHD).

Rinvoq (upadacitinib)

£1,559.25
Rinvoq (upadacitinib) is a medication used to treat adults with active rheumatoid arthritis, psoriatic arthritis, atopic dermatitis, ulcerative colitis and ankylosing spondylitis.

Rivfloza (nedosiran)

Rivfloza (nedosiran) is a prescription medicine for the treatment of children (9+) and adults with primary hyperoxaluria type 1 (PH1) and relatively preserved kidney function1. Rivfloza (nedosiran) is approved by the FDA in the USA 2.

RoActemra (tocilizumab)

£1,990.00
RoActemra (tocilizumab) is a medicine used for the treatment of severe COVID-19, rheumatoid arthritis, systemic juvenile idiopathic arthritis or juvenile idiopathic polyarthritis. It is approved by the Food and Drugs Administration (FDA), USA, under the brand-name Actemra.